This inventor holds 8 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2000-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2009
Title: Mark S. Jensen: Innovator in Pharmaceutical Chemistry
Introduction
Mark S. Jensen is a prominent inventor based in Holmdel, NJ (US), known for his significant contributions to pharmaceutical chemistry. With a total of 8 patents, he has made remarkable advancements in the field, particularly in the development of CCR-2 antagonists.
Latest Patents
Among his latest patents is the CCR-2 antagonist salt, which details an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl} cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt. This succinate salt is crystalline and exhibits superior properties. Another notable patent is the process for the preparation of CCR-2 antagonists, which provides an efficient synthesis for the same compound and its intermediates.
Career Highlights
Mark S. Jensen is currently associated with Merck & Co., Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing drug development processes and improving therapeutic options.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues such as Chunhua Yang and Nobuyoshi Yasuda, further enhancing the impact of his research and inventions.
Conclusion
Mark S. Jensen stands out as a key figure in pharmaceutical innovation, with a focus on developing effective treatments through his patented inventions. His contributions continue to shape the future of drug development and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile